Ethylenediamine Dihydrochloride
A largely retired cream stabiliser that still matters — because it cross-reacts with common antihistamines and an asthma drug
INCIEthylenediamine
- Category
- Irritant
- Risk level
- medium
- The real risk is drugs, not creams
- Largely removed from topicals — but a positive test flags reactions to systemically given cross-reactors
- Cross-reactors
- Aminophylline (asthma/COPD) and piperazine antihistamines — hydroxyzine, cetirizine
- Systemic contact dermatitis
- Skin sensitisation can become a widespread rash when a cross-reactive drug is taken orally or IV
Look for these names on ingredient lists
This ingredient may appear under any of these names:
Commonly found in
Possible reactions
- Allergic contact dermatitis from topical preparations
- Systemic contact dermatitis after taking aminophylline or a piperazine antihistamine
- Widespread rash/urticaria from a cross-reactive drug
What is ethylenediamine dihydrochloride?
Ethylenediamine dihydrochloride (INCI: Ethylenediamine; 1,2-diaminoethane dihydrochloride; EDA) is a diamine once widely used as a stabiliser in topical creams. As a cosmetic/pharmaceutical ingredient it's far less common than it used to be — it was removed from many older formulations once its allergenicity was recognised. But it remains a standard patch-test allergen, not because it's prevalent today, but because a positive result has important implications for how a patient responds to certain systemic drugs.
Why it causes reactions
Ethylenediamine is a reactive diamine — its two amine groups readily bind skin proteins to form haptens, driving Type IV delayed hypersensitivity. Its standout feature is cross-reactivity with systemically administered drugs:
- Aminophylline (asthma/COPD) is an ethylenediamine–theophylline complex; a sensitised person can develop systemic contact dermatitis — a widespread rash — when given it.
- Piperazine antihistamines — hydroxyzine and cetirizine — are structurally related; ethylenediamine-sensitised people may react to these very commonly prescribed drugs (an antihistamine meant to treat itch instead causing a rash).
- Some imidazole antifungals may cross-react in certain patients.
This systemic contact dermatitis mechanism — skin sensitisation leading to a body-wide reaction when a cross-reactive compound is taken orally or IV — is a classic, important concept.
Ethylenediamine matters less for what's in your cream now and more for what your doctor might prescribe later. A confirmed allergy is worth telling every clinician — so they steer clear of aminophylline and the piperazine antihistamines (hydroxyzine, cetirizine) that can set off a widespread reaction.
Where it's found
- Older topical creams — as a pH stabiliser (now uncommon).
- Some ophthalmic preparations — as a stabiliser.
- Aminophylline-containing medicines — relevant via cross-reaction, not as a cosmetic.
On labels: Ethylenediamine, Ethylenediamine Dihydrochloride, 1,2-Diaminoethane.
Safer alternatives
- Non-piperazine antihistamines — loratadine, fexofenadine, desloratadine, diphenhydramine.
- Plain theophylline instead of aminophylline (prescriber's decision).
- Modern topicals — generally ethylenediamine-free already.
The bottom line
Ethylenediamine is a mostly-retired cream stabiliser that punches above its weight on patch-test panels — because a positive flags potential reactions to aminophylline and the piperazine antihistamines (hydroxyzine, cetirizine) given systemically. If you're sensitised, the real action item is to tell your clinicians so they pick non-cross-reacting drugs.
Was this article helpful?
One tap tells us what to write more of. No account needed.
Is this ingredient in your products?
Scan any cosmetic product to check for Ethylenediamine Dihydrochloride and 30+ other allergens instantly.